multiple sclerosis news

Roche, multiple sclerosis

US FDA approves injectable version of Roche's multiple sclerosis therapy

The U.S. Food and Drug Administration on Thursday approved Roche's under-the-skin injection to treat patients with multiple sclerosis. The therapy is already approved as an infusion or IV therapy for multiple sclerosis,

News Medical on MSN · 17h

Therapeutic inertia in the treatment of women with multiple sclerosis revealed

A study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS), highlighting gender disparities that could impact long-term health outcomes for women of childbearing age.

Business Insider · 3d

Roche's OCREVUS ZUNOVO Gets FDA Approval To Treat Relapsing And Progressive Multiple Sclerosis

Swiss drug major Roche (RHHBY) announced Monday that the United States Food and Drug Administration has approved OCREVUS ZUNOVO

STAT · 6d

FDA approves Roche’s injectable version of blockbuster multiple sclerosis drug

Patients will be able to get a 10 minute injection of the Roche drug, instead of an hours-long infusion. Novartis already has its own injectable MS drug, Kesimpta.

MarketWatch · 6d

Roche Gets FDA Approval for Multiple-Sclerosis Treatment

Roche Holding's Genentech unit said the Food and Drug Administration approved its twice-yearly, subcutaneous injection treatment for patients with two types of multiple sclerosis. The treatment, called Ocrevus Zunovo,

Medpage Today on MSN1d

Higher Comorbidity Burden in Multiple Sclerosis Tied to Worse Outcomes

Higher comorbidity burden among people with multiple sclerosis (MS) was associated with worse clinical outcomes, pooled trial ...

Multiple Sclerosis News Today1d

ECTRIMS 2024: Mavenclad sustains benefits in relapsing MS

A short course of Mavenclad can provide long-term reductions in disease activity and disability progression in highly active ...

1don MSN

Early treatment significantly reduces long-term disability in children with multiple sclerosis, new study finds

New research presented today at European Committee for Treatment and Research in Multiple Sclerosis 2024 reveals that ...

News Medical on MSN1d

$1 Million Grant to Fund Research of Nerve Regeneration in Multiple Sclerosis Patients

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Medscape6d

Does Multiple Sclerosis Protect Against Alzheimer's?

Patients with MS showed half the rate of amyloid pathology compared with people without MS, suggesting a possible protective ...

EurekAlert!2d

Ancestry-specific genetic variants linked to multiple sclerosis risk, new study shows

The research, presented today at ECTRIMS 2024, is the result of efforts by the Alliance for Research in Hispanic MS (ARHMS) Consortium and is the first large-scale study to identify ancestry-specific ...

News Medical2d

Study uncovers ancestry-specific genetic links to multiple sclerosis risk

A landmark study has uncovered novel ancestry-specific genetic variants linked to multiple sclerosis (MS), offering new insights that could reshape treatment approaches for diverse populations ...

Philadelphia Tribune6d

Philadelphia summit to focus on increasing awareness of multiple sclerosis in Black communities

Multiple sclerosis was once thought to primarily affect white people of European ancestry, so many treatments and diagnostic ...

Novartis' Multiple Sclerosis Drug Data Shows Most Patients Remain With No Disability Progression For Up To Six Years

Novartis' new data for Kesimpta showed reduced disability progression in relapsing multiple sclerosis patients. Continuous ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Related topics